The Medication-assisted Treatment Market Is Driven By An Increasing Dependency On Telemedicine

New York, United States, 2022-May-18 — /EPR Network/ —

With start-ups investing heavily in AI projects (inclusive of several types of robotic systems), precise workflows are rendered, as automation won’t leave any scope for errors. There is, as such, limitless scope to use automated systems and robotic helpers in modern-day hygiene, remote diagnostics, surgery, and diagnostics. Precision healthcare would be the buzzword. Thus, the Medication-assisted Treatment Market would be going automation ways going forward.

A large population is addicted to some kind of illicit drug, opioid is one of the drug class responsible for a greater number abuse and death cases. The recurrent use of opioid can cause chronic brain disorder which ultimately leads to death if not cured or supported well.

Medication-assisted treatment is one of the key treatment plans set by healthcare bodies to end this global problem. Medication-assisted treatment is a combination of approved drug types that are beneficial to end the opioid dependency with counseling and behavioral therapies. It lessens the cravings and withdrawal symptoms of opioid.

Get Free sample Copy of Medication Assisted Treatment market report@ https://www.persistencemarketresearch.com/samples/29482

The global market for medication-assisted treatment has a tremendous value potential. The market value is influenced with the significant number of initiatives held by bodies to end the opioid crisis, WHO is involved in making medication-assisted treatment as a gold standard to assist addicted patients. There are restraining factors present in the market which lowers the adoption of such method in comparison.

There are inpatient and outpatient facilities available for patients with drug abuse habits, the expenditure in such facilities is considerably high. In addition, there is a shortage of such facilities practicing counselling and therapies, well observed in developing countries. Still, medication-assisted treatment comes out as a better alternative for such traditional recovery methods. It is estimated that less than half of the people who struggle with drug abuse disorders are going medication-assisted treatment in US.

Access the “Table of Content” of Medication Assisted Treatment market report@ https://www.persistencemarketresearch.com/toc/29482

Market Segmentation:

Treatment Type

• Drug Type
  • Buprenorphine
  • Methadone
  • Naltrexone

Counselling and therapies

• End User
  • Hospital
  • Rehabilitation Clinic
  • Home care setting

On the basis of geography, global medication-assisted treatment market is segmented into regions viz. North America, Europe, East Asia, South Asia, Latin America, Oceania and Middle East & Africa. North America is undoubtedly the biggest in terms of value for medication-assisted treatment market, the adoption rate for medication-assisted treatment practice is considerably high in the US.

Prebook our Medication Assisted Treatment market report@ https://www.persistencemarketresearch.com/checkout/29482

Globally the market for medication-assisted treatment consists of pharmaceutical manufacturers with diverse nature. Some of the players operating in the medication-assisted treatment market include BioDelivery Sciences International, Inc., Teva Pharmaceuticals, Titan Pharmaceuticals, Inc, Rosemont Pharmaceuticals Limited.

About us: Persistence Market Research

Contact us:

Persistence Market Research          
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com